LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Cost of Revenue

Cost of Revenue analysis for YSBPW.

Quarterly Cost of Revenue

$101.12M

As of Mar 31, 2024

Annual Cost of Revenue (TTM)

$187.49M

Trailing 12 months ending Mar 31, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin